Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To compare the bioavailability and characterise the pharmacokinetic profile of the sponsor's
test formulation with respect to the reference formulation Cellcept® 500 mg tablets, in
healthy, adult, human male subjects under fasting conditions and to assess the
bioequivalence.